LAMA3 and ovarian carcinoma: Ovarian cancer patients with low LAMA3 expression are associated with poorer OS and PFS (OS:60.00(95%CI 46.63–73.57) VS 46.00(95%CI 31.51–60.49),P = 0.021; PFS:64.00(95%CI 36.71–91.29) VS 29.00(95%CI 3.97–54.03), P = 0.002).